| Literature DB >> 29331282 |
Maheer Khan1, Pablo Lamelas1, Hadi Musa2, Jared Paty1, Tara McCready2, Robby Nieuwlaat1, Eleonor Ng2, Patricio Lopez-Jaramillo3, Jose Lopez-Lopez4, Khalid Yusoff5, Fadhlina A Majid6, Kien Keat Ng7, Len Garis8, Oyere Onuma9, Salim Yusuf1, Jon-David Schwalm10.
Abstract
BACKGROUND: Cardiovascular disease (CVD) is the leading cause of death worldwide. The need to address CVD is greatest in low- and middle-income countries where there is a shortage of trained health workers in CVD detection, prevention, and control.Entities:
Mesh:
Year: 2018 PMID: 29331282 PMCID: PMC6090270 DOI: 10.1016/j.gheart.2017.11.002
Source DB: PubMed Journal: Glob Heart ISSN: 2211-8160
Figure 1Task-sharing to expand the pool of human resources for health.
Figure 2Elements of the World Health Organization Global HEARTS Initiative.
HOPE-4 module descriptions
| Number | Module | Description | Objective(s) |
|---|---|---|---|
| 1 | Health and Disease | Defining the terms health, disease, and risk factors | Understand key definitions |
| 2 | Organization and Communication Skills | Outlining necessary organization and communication skill required of NPHW | Become aware of the required skill set of an NPHW |
| 3 | The Cardiovascular System | Introduction to the cardiovascular system, components/functions, and diseases that affect it | Have a basic understanding of how the cardiovascular system functions |
| 4 | Risk Factors for Cardiovascular Disease | Risk factors contributing to CVD | To understand that substance abuse, poor diet, and lack of physical activity are risk factors for CVD |
| 5 | Cardiovascular Risk Assessment | Quantifying CVD risk factors | To understand how to use the WHO/PEN risk assessment charts |
| 6 | Cardiovascular Risk Prevention and Treatment | Counseling techniques for lifestyle and disease-related risk modification | To learn the various counseling techniques used in CVD prevention, treatment, and management |
| 7 | Pharmacological Management of Cardiovascular Disease | Aspects of pharmacology such as indications, contraindications, side effects, and mechanisms of action | Have a basic understanding of how different drugs can be used to manage CVD |
| 8 | HOPE-4 Program Specific Training | Administrative and logistical issues related to the HOPE-4 program | To understand the role of an NPHW in the HOPE-4 program |
| 9 | Observed Standardized Clinical Evaluation | Final evaluation of NPWH | Successfully pass all OSCE scenarios |
CVD, cardiovascular disease; HOPE-4, Heart Outcomes Prevention and Evaluation Program; NPHW, nonphysician health care worker; OSCE, objective structure clinical examinations; PEN, Package of Essential Noncommunicable; WHO, World Health Organization.
NPHW characteristics
| Malaysia (n = 30) | Colombia (n = 13) | Canada (n = 8) | Overall (n = 51) | |
|---|---|---|---|---|
| Women, % | 60 | 85 | 25 | 61 |
| Type of NPHW (number trained) | Nurses (16) | Nursing assistants (13) | Community health workers (4) | |
| Medical assistants (3) | ||||
| Research assistants (11) | Firefighters (4) | |||
| Prior experience in health care, % | 33 | 85 | 13 | 43 |
| Prior experience in CVD prevention, % | 33 | 15 | 13 | 26 |
Abbreviations as in Table 1.
Figure 3Mean module test scores. Bar = ± 1 SD.
Figure 4Mean objective structured clinical examinations (OSCE) scores. Bar = ± 1 SD.
Figure 5Nonphysician health care worker (NPHW) feedback questionnaire results (n = 26). CV, cardiovascular; CVD, cardiovascular disease.